Project Grant DP2AI184813
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$451K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This $126,174 federal Project Grant awarded on May 29, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research program) will support research at the University of California, Davis to investigate the local immune response in bacterial skin infections using a novel skin-on-a-chip model. The overarching goals are to gain mechanistic insights into the migration of hematopoietic stem and progenitor cells (HSPCs) into human skin and...
The federal Project Grant award R01AI182143, totaling $506,394.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to define the molecular and cellular mechanisms by which bacterial cholesterol-dependent cytolysins (CDCs) can reorganize host organelles and activate the NLRP3 inflammasome signaling pathway. This research aims to help characterize CDCs as potential...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research, will support research to understand how caloric restriction can enhance immune memory and improve pathogen control. The $631,977 award to Weill Medical College of Cornell University aims to reveal the molecular mechanisms by which caloric restriction increases memory CD8+ T cell function and microbiome-derived acetate...
This federal Project Grant award of $637,275 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to uncover the mechanisms by which bacterial pathogens rapidly develop tolerance to chemical stressors, such as antibiotics. The research aims to define novel stress tolerance mechanisms in pathogens, with implications for improving antibacterial therapies and public health. Key focus areas...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $244,440.00 to the Albert Einstein College of Medicine to conduct research on how Ly6C+ monocytes respond to and help clear microbial pathogen infections. The research aims to define the chemotactic cues, receptors, and mechanisms involved in how these monocytes home to infection sites and form stable clusters to deliver local...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $192,500.00 to the University of South Alabama to conduct research on the mechanisms of Borrelia burgdorferi central nervous system invasion in a mouse model of Lyme disease. The goal is to identify key pathways of bacterial entry into the central nervous system and associated host immune responses, which could...
This $453,900 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding research to develop a genome editing platform using broadly functioning phage recombinases, which can be used to genetically manipulate a wide range of bacterial species, including clinically relevant pathogens. The goal is to enable direct investigation of the genetic elements driving bacterial...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $227,018 to the University of California, Irvine (UCI) from May 1, 2025 to April 30, 2027. The project aims to determine the role of microglia, brain-resident immune cells, in defending against Toxoplasma gondii infection in the context of AIDS-associated immune deficiency. Key objectives include examining...
This Project Grant award, totaling $891,678.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The award will fund a project at the Scripps Research Institute in La Jolla, CA focused on using chemoproteomic and functional analysis methods to identify microbiota bile acid-protein targets and characterize their mechanisms of action on host immunity. The goal is to better understand how...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $492,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct systematic genetic research on the mechanisms governing immunogenic cell death (ICD). The research aims to decipher the signaling pathways and molecular processes that regulate the immune system's ability to recognize...